Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
Press ReleaseCardiawave lauréate de la première promotion French Tech Health20 Apr 14, 2023 READ MORE
EventsCardiawave présente à la 8ème édition de la « Journée start-up innovantes du dispositif médical » – Apr. 4 – Paris Apr 13, 2023 READ MORE
About UsCardiawave est lauréate de la première promotion du French Tech Health20 ! Mar 27, 2023 READ MORE
Clinical Studies2 patients treated last week in our new clinical study site OLVG! Mar 15, 2023 READ MORE
Clinical Studies20 patients treated in our on-going European Valvosoft® Pivotal Study ! Feb 27, 2023 READ MORE
Press ReleaseCardiawave granted 3 new patents extending its intellectual property protection for its technology in the United States Feb 14, 2023 READ MORE
About UsNous sommes fiers d’annoncer que Cardiawave vient de devenir membre de la French Care ! Jan 26, 2023 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
